Researchers identify a new approach to detect the early progression of brain tumors

Aug 28, 2008

Researchers at Barrow Neurological Institute at St. Joseph's Hospital and Medical Center recently participated in a pilot study with the Montreal Neurological Institute that suggests a certain type of MRI scanning can detect when a patient is failing brain tumor treatment before symptoms appear. The results of the study pave the way for a proactive treatment approach.

The study followed patients with recurring malignant brain tumors who were receiving chemotherapy. Patients received scans through an imaging device called MR spectroscopy to identify metabolic changes. The scanning technique suggested that the use of metabolic imaging identifies chemical changes earlier than structural imaging such as a conventional MRI and CT scans.

This approach allowed researchers to determine if the tumors were responding to treatment early by assessing metabolic changes in a brain tumor, which are easy to detect and appear before structural changes or symptoms. The result may give patients more time to try another treatment.

"The study has shown for the first time that metabolic response to brain tumor treatment can be detected earlier and faster by metabolic imaging instead of through structural imaging or assessment of the neurological status of a patient," says Mark C. Preul, M.D., Newsome Chair of Neurosurgery Research at St. Joseph's.

The imaging can be done often, poses no radiation hazard and is non-invasive.

"Frequent use of this type of imaging may be a useful tool to follow a patient's response to chemotherapy for malignant brain tumors," says Dr. Preul. "It gives us the ability to identify treatment failure early and more time to alter a patient's treatment plan before the disease progresses."

As a result of the pilot study, Barrow researchers are planning to conduct a second study that will use imaging in the same way to monitor the effects of brain tumor treatment. They are also developing imaging modalities that will show how brain tumors change their shape and metabolism with treatment.

Source: St. Joseph's Hospital and Medical Center

Explore further: Green tea ingredient may target protein to kill oral cancer cells

add to favorites email to friend print save as pdf

Related Stories

Stunning zinc fireworks when egg meets sperm

Dec 15, 2014

Sparks literally fly when a sperm and an egg hit it off. The fertilized mammalian egg releases from its surface billions of zinc atoms in "zinc sparks," one wave after another, a Northwestern University-led ...

Clearer future for blind thanks to vOICe device

Dec 12, 2014

New findings from researchers in our Department of Psychology could pave the way for better treatments for blind and partially-sighted people using the revolutionary sensory substitution device, 'The vOICe'. ...

What exactly is Google's 'cancer nanodetector'?

Nov 11, 2014

Last week, US tech giants Google made a splash in the media, announcing plans to develop new 'disease-detecting magnetic nanoparticles'. This was almost universally welcomed – after all, trying to detect ...

Recommended for you

Core needle biopsy helpful with cervical lymphadenopathy

13 hours ago

(HealthDay)—Core needle biopsy (CNB) is a more sensitive tool than fine-needle aspiration cytology (FNAC) for cervical lymphadenopathy evaluation, according to a study published in the February issue of ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.